CAS NO: | 172733-42-5 |
生物活性 | Varespladib sodium (LY315920 sodium) is a potent and selectivegroup IIA, secretoryphospholipase A2(sPLA2)inhibitor with anIC50of 9 nM. Varespladib sodium exhibits the significant inhibitory effect onsPLA2activity in serum from various species including rat, rabbit, guinea pig and human withIC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | Varespladib sodium (10 μM; 24 and 48 hours; HCjE cells) treatment results in complete inhibition of the RA-induced increase in MUC16 protein detected in cell lysates at both time points[2]. Western Blot Analysis[2]
RT-PCR[2]
| ||||||||||||||||
体内研究 (In Vivo) | Varespladib sodium treatment inhibits human sPLA2-induced release of thromboxane A2(TXA2) from isolated guinea pig lung bronchoalveolar lavage cells with anIC50of 0.79 μM. And theED50for Varespladib sodium is 16.1 mg/kg[1].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 402.38 | ||||||||||||||||
Formula | C21H19N2NaO5 | ||||||||||||||||
CAS 号 | 172733-42-5 | ||||||||||||||||
中文名称 | 伐瑞拉迪钠;伐瑞拉地钠 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |